ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Bioprosthetic Mitral Valve Replacement in Patients Aged 65 Years or Younger: Long-Term Outcomes With the Carpentier–Edwards PERIMOUNT Pericardial Valve

Thursday, February 15, 2018

Submitted by

Benjamin Bidstrup

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezy029

Author(s)

Thierry Bourguignon, Fabien Espitalier, Clémence Pantaleon, Emmanuelle Vermes, Jean Marc El-Arid, Claudia Loardi ,Elias Karam, Pascal Candolfi, Fabrice Ivanes, Michel Aupart

This report provides long-term outcome data on the Perimount valve implanted in the mitral position in patients 65 years of age or less. The expected valve durability was 14.2 years, which compares favourably with other prosthetic valves. Long term mortality was considered valve-related in 1.3% per valve-years, with an overall mortality of 4% per valve-years. The authors provide useful predictions of valve degeneration rates and need for reoperative surgery.